مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

111
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

88
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Soy Isoflavone Genistein Is a Potential Agent for Metabolic Syndrome Treatment: A Narrative Review

Pages

  164-175

Abstract

Metabolic syndrome has a high prevalence (about 22. 4% in adult individuals) in developed countries. Inflammation due to obesity and fat accumulation is the most important factor in the progression of Metabolic syndrome. In cells which have a receptor for insulin hormone, inflammatory mediators target the insulin signaling pathway and cause Insulin resistance. Peroxisome proliferator-activated receptors are a group of ligand inducible transcription factors, whose activation can improve Insulin resistance and their agonists such as Genistein, which seems to be useful in prevention of Insulin resistance development. Genistein is one of the soy derived isoflavonoids that affects carbohydrate and lipid metabolism resulting in prevention of Insulin resistance. The current narrative review has concentrated mainly on highlighting the usefulness of Genistein in the improvement of Insulin resistance and therapeutic potential of it in both in-vitro and in-vivo models. Genistein can increase fatty acid β-oxidation, decrease lipogenesis and improve Insulin resistance in hepatocytes. In adipocytes, Genistein prevents downregulation of adiponectin expression and facilitates the upregulation of adiponectin expression. In β-islet cells, Genistein initiates the special cascade which leads to proliferation of β cells, resulting in increased secretion of insulin. Based on findings of the studies, it can be concluded that Genistein can be a useful agent in prevention of de novo lipid synthesis as well as proliferation of β cells. In this way the development of Metabolic syndrome can be prevented.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    Ghadimi, Darya, HEMMATI, MINA, KARIMI, NEGAR, & Khadive, Tooka. (2020). Soy Isoflavone Genistein Is a Potential Agent for Metabolic Syndrome Treatment: A Narrative Review. JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH, 28(127), 164-175. SID. https://sid.ir/paper/747143/en

    Vancouver: Copy

    Ghadimi Darya, HEMMATI MINA, KARIMI NEGAR, Khadive Tooka. Soy Isoflavone Genistein Is a Potential Agent for Metabolic Syndrome Treatment: A Narrative Review. JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH[Internet]. 2020;28(127):164-175. Available from: https://sid.ir/paper/747143/en

    IEEE: Copy

    Darya Ghadimi, MINA HEMMATI, NEGAR KARIMI, and Tooka Khadive, “Soy Isoflavone Genistein Is a Potential Agent for Metabolic Syndrome Treatment: A Narrative Review,” JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH, vol. 28, no. 127, pp. 164–175, 2020, [Online]. Available: https://sid.ir/paper/747143/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button